Immunomodulation Effect of Convalescent Plasma Therapy in Severe - Critical COVID-19 Patients.

Munawaroh FitriahAditea Etnawati PutriBambang Pujo SemediAtika AtikaBetty Agustina Tambunan

Published in: Open access emergency medicine : OAEM (2023)

No correlation between the increase in s-RBD IgG levels and changes in IL-4 and IL-6 levels. Changes in s-RBD IgG, IL-4, and IL-6 levels are not associated with mortality in severe-critical COVID-19 degree post CPT recipients.

Keyphrases

sars cov
early onset
risk factors
type diabetes
cardiovascular disease
bone marrow
smoking cessation
cell therapy